From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets

This study follows 36 Italian adults with polycythemia vera, a blood cancer, who have been responding well to the drug Ropeginterferon alfa-2b for at least two years. Researchers will check every six months whether their red blood cell levels stay controlled and the disease does …

This study is testing a mobile app called ePro-Diary HDV to help people with hepatitis D (HDV) manage their condition. The app lets patients track lab results, answer quality-of-life questions, and communicate with their doctors. The goal is to see if using the app helps patients…

This study follows 617 adults diagnosed with myelofibrosis (a rare bone marrow cancer) across Europe. Researchers will collect routine medical data to see how low blood cell counts at diagnosis affect survival and treatment response. No new treatments are tested; the goal is to l…

This study is testing a digital tool to help young people (ages 14–20) who have had or are waiting for a liver transplant as they move from pediatric to adult medical care. The tool is designed to help patients and their families manage their health remotely, reducing the need fo…

This study aims to find out how many people with hepatitis B also have hepatitis delta, a more serious liver infection. Researchers will test 244 adults in hospitals, addiction clinics, and prisons in Bergamo, Italy. The goal is to improve detection and connect patients to care.

This study looks at people with a blood condition called essential thrombocythemia (ET) who later develop polycythemia vera (PV), a related disorder. Researchers want to find out what factors cause this change and whether these patients have different outcomes than those diagnose…